Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-11-04

FDA Approved: ENTECAVIR — Original Application (Yaopharma Co., Ltd.)

View source ↗

Summary

FDA approved Yaopharma Co., Ltd.'s entecavir as an original application (ANDA212201).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENTECAVIR (ENTECAVIR)

Snippet

ORIG AP for ENTECAVIR (ENTECAVIR)